Berberine inhibits gastric cancer progression by targeting canonical Wnt/β-catenin signaling in AGS cells.

Xiao L, Hui R, Jing B

Open source

DOI
10.1007/s00210-026-05955-w
Published
2026 Oct 9
Container
Naunyn-Schmiedeberg's archives of pharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05955-w,
  title = {Berberine inhibits gastric cancer progression by targeting canonical Wnt/β-catenin signaling in AGS cells.},
  author = {Xiao L and Hui R and Jing B},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's archives of pharmacology},
  doi = {10.1007/s00210-026-05955-w},
  url = {https://doi.org/10.1007/s00210-026-05955-w}
}

RIS

TY  - JOUR
TI  - Berberine inhibits gastric cancer progression by targeting canonical Wnt/β-catenin signaling in AGS cells.
AU  - Xiao L
AU  - Hui R
AU  - Jing B
PY  - 2026
JO  - Naunyn-Schmiedeberg's archives of pharmacology
DO  - 10.1007/s00210-026-05955-w
UR  - https://doi.org/10.1007/s00210-026-05955-w
ER  - 

APA

L, X., R, H., & B, J. (2026). Berberine inhibits gastric cancer progression by targeting canonical Wnt/β-catenin signaling in AGS cells.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05955-w

Source records